BioTissue Reports Promising Phase 2 Trial Results for New Dry Eye Treatment

New York, Friday, 9 October 2026.
BioTissue announced positive Phase 2 clinical results for a novel dry eye therapy derived from human birth tissue, demonstrating significant symptom relief and safety without serious adverse events.